Patents by Inventor Steven Hsesheng Lin

Steven Hsesheng Lin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antibodies and molecules that immunospecifically bind to BTN1A1 and the therapeutic uses thereof
    Patent number: 11970534
    Abstract: Provided herein are molecules having an antigen binding fragment that immunospecifically binds to BTN1A1, such as anti-BTN1A1 antibodies. These molecules include those having an antigen binding fragment that immunospecifically binds to glycosylated BTN1A1, such as anti-glycosylated BTN1A1 antibodies. Methods of making and using these molecules are also provided, including methods of using them in cancer therapies, or as cancer diagnostics.
    Type: Grant
    Filed: November 24, 2020
    Date of Patent: April 30, 2024
    Assignees: STCUBE & CO., INC., Board of Regents, The University of Texas System
    Inventors: Stephen Sunghan Yoo, Michael Joseph Surace, Steven Hsesheng Lin, Amrish Sharma
  • ANTIBODIES AND MOLECULES THAT IMMUNOSPECIFICALLY BIND TO BTN1A1 AND THE THERAPEUTIC USES THEREOF
    Publication number: 20210147537
    Abstract: Provided herein are molecules having an antigen binding fragment that immunospecifically binds to BTN1A1, such as anti-BTN1A1 antibodies. These molecules include those having an antigen binding fragment that immunospecifically binds to glycosylated BTN1A1, such as anti-glycosylated BTN1A1 antibodies. Methods of making and using these molecules are also provided, including methods of using them in cancer therapies, or as cancer diagnostics.
    Type: Application
    Filed: November 24, 2020
    Publication date: May 20, 2021
    Inventors: Stephen Sunghan Yoo, Michael Joseph Surace, Steven Hsesheng Lin, Amrish Sharma
  • Antibodies and molecules that immunospecifically bind to BTN1A1 and the therapeutic uses thereof
    Patent number: 10875920
    Abstract: Provided herein are molecules having an antigen binding fragment that immunospecifically binds to BTN1A1, such as anti-BTN1A1 antibodies. These molecules include those having an antigen binding fragment that immunospecifically binds to glycosylated BTN1A1, such as anti-glycosylated BTN1A1 antibodies. Methods of making and using these molecules are also provided, including methods of using them in cancer therapies, or as cancer diagnostics.
    Type: Grant
    Filed: December 1, 2016
    Date of Patent: December 29, 2020
    Assignees: STCUBE & CO., INC., Board of Regents, The University of Texas System
    Inventors: Stephen Sunghan Yoo, Michael Joseph Surace, Steven Hsesheng Lin, Amrish Sharma
  • ANTIBODIES AND MOLECULES THAT IMMUNOSPECIFICALLY BIND TO BTN1A1 AND THE THERAPEUTIC USES THEREOF
    Publication number: 20180355035
    Abstract: Provided herein are molecules having an antigen binding fragment that immunospecifically binds to BTN1A1, such as anti-BTN1A1 antibodies. These molecules include those having an antigen binding fragment that immunospecifically binds to glycosylated BTN1A1, such as anti-glycosylated BTN1A1 antibodies. Methods of making and using these molecules are also provided, including methods of using them in cancer therapies, or as cancer diagnostics.
    Type: Application
    Filed: December 1, 2016
    Publication date: December 13, 2018
    Inventors: Stephen Sunghan Yoo, Michael Joseph Surace, Steven Hsesheng Lin, Amrish Sharma
  • SCREENING METHODS FOR TARGETS FOR CANCER THERAPY
    Publication number: 20180156800
    Abstract: In vitro and in vive methods for screening for targets for cancer therapy are provided herein. Methods contemplate screening for targets that contribute to the immunosuppressive environment for the tumor cells, especially those targets that are associated with radiation treatment. Thus, methods provided herein are useful for identifying potential targets useful for providing cancer therapeutic agents that can be used either alone or in combination with radiation therapy.
    Type: Application
    Filed: May 20, 2016
    Publication date: June 7, 2018
    Inventors: Steven Hsesheng Lin, Stephen Sunghan Yoo